Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection

被引:14
作者
Knorr, Corinna W.
Allen, Stanley D.
Torres, Anthony R.
Smee, Donald E. [1 ]
机构
[1] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA
[2] Utah State Univ, Ctr Persons Disabilities, Logan, UT 84322 USA
关键词
orthopoxvirus; cowpox; vaccinia; cidofovir; antiviral; cytokines;
D O I
10.1016/j.antiviral.2006.05.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytokine profiles during cowpox and vaccinia (WR strain) virus infections were characterized in intranasal (i.n.) and intraperitoneal (i.p.) models in BALB/c mice. The time-course of induction and effects of cidofovir treatment on interferon (IFN)-gamma, IFN-gamma inducible protein (IP)-10, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1 were determined. The four mouse infection models have distinct patterns of cytokine induction. Cowpox virus i.p. and vaccinia virus i.n. infections showed increased induction throughout the time studied. Cowpox virus i.n. infection resulted in delayed induction of IFN-gamma and IP-10. Cytokine levels were fairly constant during vaccinia virus i.p. infections. Cidofovir treatment (100 mg/kg/day i.p. for 2 days) significantly suppressed certain cytokine (IFN-gamma, IL-6, IL-10, IL-11, IP-10, LIF, MCP-1, MCP-3, MCP-5, MIP-1 gamma, and TIMP-1) levels to near normal relative to uninfected animals, as well as prevented mortality and reduced virus titers significantly. Characterization of cytokine responses has implications for understanding the immune responses and pathogeneses of viral infections in these mouse models. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 41 条
[1]  
Alcamí A, 1998, J IMMUNOL, V160, P624
[2]  
Amichay D, 1996, J IMMUNOL, V157, P4511
[3]  
BIRON CA, 2001, FIELDS VIROLOGY, P321
[4]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[5]   Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge [J].
Bray, M ;
Martinez, M ;
Smee, DF ;
Kefauver, D ;
Thompson, E ;
Huggins, JW .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :10-19
[6]  
CARPENTER EA, 1994, J IMMUNOL, V152, P2652
[7]   Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox [J].
Chaudhri, G ;
Panchanathan, V ;
Buller, RML ;
van den Eertwegh, AJM ;
Claassen, E ;
Zhou, J ;
de Chazal, R ;
Laman, JD ;
Karupiah, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9057-9062
[8]   Cutting edge: Long-term B cell memory in humans after smallpox vaccination [J].
Crotty, S ;
Felgner, P ;
Davies, H ;
Glidewell, J ;
Villarreal, L ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4969-4973
[9]  
De Maeyer Edward, 1998, P491
[10]   PREVENTION OF VACCINIA VIRUS-INFECTION IN IMMUNODEFICIENT MICE BY VECTOR-DIRECTED IL-2 EXPRESSION [J].
FLEXNER, C ;
HUGIN, A ;
MOSS, B .
NATURE, 1987, 330 (6145) :259-262